Healthcare Industry News: Bayer HealthCare
News Release - March 11, 2008
Bayer HealthCare Pharmaceuticals Introduces VistaTrak(TM) an Innovative Contrast Media Management SystemFirst-of-its kind, RFID-enabled system addresses complex issues associated with the utilization of contrast media
WAYNE, N.J., March 11 (HSMN NewsFeed) -- Bayer HealthCare Pharmaceuticals Inc., a leader in diagnostic imaging, unveiled plans to launch VistaTrak(TM), an innovative contrast media management system that provides radiology departments with a new and powerful management tool to help enhance patient care and safety, optimize inventory management and improve billing accuracy.
VistaTrak is a collaboration between Bayer HealthCare Pharmaceuticals and Mobile Aspects, an industry leader in providing Radio Frequency Identification (RFID)-enabled solutions for healthcare and hospital environments. The companies worked together to optimize Mobile Aspects' proprietary iRIS(TM) platform for the unique needs and requirements of the radiology environment. Bayer is the first company to offer a contrast media management system based on an RFID platform to automate manual processes and capture valuable operational data that currently cannot be found in any one system.
The VistaTrak contrast media management system was previewed at the 2007 Radiological Society of North America (RSNA) 93rd Scientific Assembly and Annual Meeting last November, where it was well-received. The system combines RFID technology of "tagged" bottles of contrast agent with a "smart" cabinet and a specially designed interface to capture, store and manage product utilization data easily and reliably while helping to reduce the risk of human error. It helps radiology departments and administrators by providing radiology-specific solutions for the use of contrast media, such as:
-- Facilitating patient safety by automatically screening data from a patient's electronic medical record (EMR) for, among other things, contraindications and prior adverse events
-- Capturing important information stored on the tag, such as NDC number, expiration date and lot number, automatically and in an efficient manner that supports compliance with accrediting organization requirements
-- Providing accurate contrast dosing information to improve billing accuracy and help address any existing issues with reimbursement or audits
-- Tracking inventory to enable departments to order and manage inventory more efficiently and reduce waste
VistaTrak features an easy-to-use, touch-screen interface and is available in two different sizes to address varying usage needs.
"Our new, cutting-edge VistaTrak system addresses some of the most pressing concerns confronting radiology departments today, such as patient safety and the increasing requirements by accrediting organizations on the storage, handling and use of contrast media," said Douglas Stefanelli, Vice President and General Manager, Diagnostic Imaging, Bayer HealthCare Pharmaceuticals. "This is the first time RFID technology is being employed in this unique way in the radiology suite, and is an example of how Bayer HealthCare continues to innovate in radiology and helps improve patient care."
"Collaborating with Bayer HealthCare Pharmaceuticals to help address challenges in the radiology setting has provided us with another opportunity to showcase the versatility and benefits of our advanced and patented RFID- based systems in a hospital and healthcare environment," said Suneil Mandava, President and Chief Executive Officer, Mobile Aspects. "Mobile Aspects is looking forward to working with Bayer in supporting VistaTrak and its ability to help radiology departments more effectively manage risk and potentially improve the business processes in all departments that touch contrast media."
About Bayer HealthCare Pharmaceuticals
Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals unit of Bayer HealthCare LLC, a division of Bayer AG. One of the world's leading, innovative companies in the healthcare and medical products industry, Bayer HealthCare combines the global activities of the Animal Health, Consumer Care, Diabetes Care, and Pharmaceuticals divisions. In the United States, Bayer HealthCare Pharmaceuticals comprises the following business units: Women's Healthcare, Diagnostic Imaging, Specialized Therapeutics, Hematology/Cardiology and Oncology. The company's aim is to discover and manufacture products that will improve human health worldwide by diagnosing, preventing and treating diseases.
About Mobile Aspects
Mobile Aspects, Inc. of Pittsburgh, Pa., is a healthcare technology supplier focused on providing an integrated suite of clinical resource management solutions to automate the management of supply, asset, drug and patient tracking through the One System of CARE solution. The cornerstone of these technological capabilities is Intelligent Radio Frequency Inventory System (iRIS(TM)), the industry's leading patent-protected tracking architecture that leverages radio frequency identification (RFID) technology. Through this innovative technology, clinicians and other care providers experience a hands free approach to managing the resources used in the patient care process.
This news release contains forward-looking statements based on current assumptions and forecasts made by Bayer Group management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in our public reports filed with the Frankfurt Stock Exchange and with the U.S. Securities and Exchange Commission (including Form 20-F). The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
Source: Bayer HealthCare
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.